Document:

EX-4.1

 Exhibit 4.1 

FIRST AMENDMENT TO COMMON STOCK PURCHASE WARRANT 

THIS FIRST AMENDMENT TO COMMON STOCK PURCHASE WARRANT (this “First Amendment”), dated as of December 20, 2018 (the
“Amendment Date”), is entered into by and between Richard E. Uihlein, an individual resident of the State of Illinois (hereinafter the “Holder”), and Galectin Therapeutics, Inc., a Nevada corporation (hereinafter
the “Company”). The Holder and the Company shall each be referred to herein individually as a “Party” and, collectively, as the “Parties.” 

RECITALS 
 WHEREAS,
the Company issued that certain Common Stock Purchase Warrant to the Holder on December 19, 2017 (the “Warrant”); and 

WHEREAS, the Parties wish to amend the Warrant in accordance with the terms of Section 10.2 thereof to
reflect certain changes as set forth herein. 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Parties agree as follows: 
 1.    Amendment to Preamble to the Warrant. The
preamble to the Warrant is hereby amended by deleting the phrase “. . .dated as of December     , 2017 . . .” and inserting the following in lieu thereof: “. . .dated as of December 19, 2017 . . .”

 2.    Amendment to Definition of “Issue Date”. Section 1 of the Warrant
(Definitions) is hereby amended by deleting the definition of “Issue Date” in its entirety and inserting the following in lieu thereof: ““Issue Date” means December 19, 2017.” 

3.    Amendment to Section 2.1 of the Warrant. Section 2.1 of the
Warrant (Vesting) is hereby amended by deleting all references to “December 31, 2018” contained therein and inserting the following in lieu thereof: “December 31, 2019”. 

4.    Miscellaneous. Except as amended by this First Amendment, the Warrant remains in full force and effect in
accordance with its terms. This First Amendment shall be governed by and interpreted in accordance with the laws of the State of Nevada. If any provision of this First Amendment or part thereof is rendered void, illegal or unenforceable in any
respect under any applicable law, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. This First Amendment may only be amended in the same manner as the Warrant. Capitalized
terms used herein without specific definition have the respective meanings given to them in the Warrant. This First Amendment may be executed in counterparts, each of which shall be deemed to be an original; provided, however, that such counterparts
shall together constitute only one instrument. A signed copy of this First Amendment transmitted by facsimile, email or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original executed copy of
this First Amendment for all purposes. 
 [Signatures Appear on the Following Page] 

 IN WITNESS WHEREOF, the Parties have duly authorized and executed this First Amendment as of
the Amendment Date. 
  

			
	By:	 	 /s/ Richard E. Uihlein

		 	Richard E. Uihlein
	
	GALECTIN THERAPEUTICS, INC.
		
	By:	 	 /s/ Harold H. Shlevin

	Name:	 	Harold H. Shlevin
	Title:	 	Chief Executive OfficerEX-10.1

 Exhibit 10.1 

FIRST AMENDMENT TO LINE OF CREDIT LETTER AGREEMENT 

THIS FIRST AMENDMENT TO LINE OF CREDIT LETTER AGREEMENT (this “First Amendment”), dated as of December 20, 2018 (the
“Amendment Date”), is entered into by and between Richard E. Uihlein, an individual resident of the State of Illinois (“Uihlein”), and Galectin Therapeutics, Inc., a Nevada corporation (the
“Company”). Uihlein and the Company shall each be referred to herein individually as a “Party” and, collectively, as the “Parties.” 

RECITALS 
 WHEREAS,
the Parties entered into a Line of Credit Letter Agreement, dated as of December 19, 2017 (the “Line of Credit”); and 

WHEREAS, the Parties wish to amend the Line of Credit to reflect certain changes as set forth herein. 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as
follows: 
 1.    Amendment to the Second Paragraph of the Line of Credit. The second paragraph of the Line of
Credit is hereby amended by: 
 (a)    deleting the words “... may be drawn upon through
December 31, 2018...” and inserting the following in lieu thereof: “... may be drawn upon through December 31, 2019...”; and 

(b)    deleting the words “... payable on or before December 31, 2019...” and
inserting the following in lieu thereof: “... payable on or before December 31, 2020...”. 

2.    Amendment to Exhibit A of the Line of Credit. Exhibit A of the Line of Credit is hereby deleted in its
entirety and replaced by Exhibit A attached hereto. 
 3.    Miscellaneous. Except as amended by this
First Amendment, the Line of Credit remains in full force and effect in accordance with its terms. This First Amendment shall be governed by and interpreted in accordance with the laws of the State of Georgia, excluding its choice of law rules. If
any provision of this First Amendment or part thereof is rendered void, illegal or unenforceable in any respect under any applicable law, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or
impaired thereby. This First Amendment may only be amended in the same manner as the Line of Credit. Capitalized terms used herein without specific definition have the respective meanings given to them in the Line of Credit. This First Amendment may
be executed in counterparts, each of which shall be deemed to be an original; provided, however, that such counterparts shall together constitute only one instrument. A signed copy of this First Amendment transmitted by facsimile, email or other
means of electronic transmission shall be deemed to have the same legal effect as delivery of an original executed copy of this First Amendment for all purposes. 

[Signatures Appear on the Following Page] 

 IN WITNESS WHEREOF, the Parties have duly authorized and executed this First Amendment as of
the Amendment Date. 
  

			
	By:	 	 /s/ Richard E. Uihlein

		 	Richard E. Uihlein
	
	GALECTIN THERAPEUTICS, INC.
		
	By:	 	 /s/ Harold H. Shlevin

	Name:	 	Harold H. Shlevin
	Title:	 	Chief Executive Officer

 EXHIBIT A 

FORM OF PROMISSORY NOTE 

PROMISSORY NOTE 
  

					
	$                                	  		  	Atlanta, Georgia
		  		  	Dated as of                            

 FOR VALUE RECEIVED, the undersigned, GALECTIN THERAPEUTICS, INC., a Nevada corporation (the
“Company”), hereby unconditionally promises to pay to the order of [Richard E. Uihlein, an individual resident of the State of Illinois] (“Lender”), whose office address is [12575 Uline Drive, Pleasant Prairie, WI
53158], on December 31, 2020 in lawful money of the United States of America and in immediately available funds, the principal amount of (a)
                                     DOLLARS
($                            ). The Company further agrees to pay interest in like money at an annual
rate of         % [the Applicable Federal Rate for short term loans as may be in effect on the date of the Promissory Note as published by the Internal Revenue Service.] on the unpaid principal amount
hereof from time to time outstanding, which shall accrue commencing on the date hereof and continuing until paid in full on December 31, 2020 or sooner prepaid. 

This Promissory Note is made pursuant to that certain Line of Credit Letter Agreement, dated as of December 19, 2017, as amended, by and
between Richard Uihlein and the Company, and the Company and the Lender are entitled to the benefits and obligations thereof. The Company may prepay any amounts due under this Promissory Note in whole or in part in its sole discretion without any
premium or penalty. 
 The Company, for itself and all other persons who now are or who may become liable for the payment of all or any part
of the obligations evidenced by this Promissory Note, jointly, severally and irrevocably, hereby waives presentment for payment, demand, protest, notice of protest, notice of dishonor and any and all other notices and demands whatsoever. The Company
shall pay all costs and expenses of collection, including, without limitation, reasonable attorneys’ fees except to the extent limited or prohibited by law. 

No act, omission, or other failure on the part of Lender or any holder of this Promissory Note to exercise any right, remedy or recourse
hereunder with respect to the Company, whether before or after the occurrence of a default, shall constitute waiver or release of any such right, remedy, recourse, default by such holder or on behalf of any other holder; such waiver or release to be
effected only through a written document executed by Lender or such holder and then only to the extent specifically recited therein. A waiver or release with reference to any one event shall not be construed as continuing, as a bar to, or as a
waiver or release of, any subsequent right, remedy or recourse as to a subsequent event. 
 This Promissory Note shall be governed by,
construed and interpreted in accordance with the laws of the State of Georgia. 

 
			
	GALECTIN THERAPEUTICS, INC.
		
	By:	 	  

	Name:	 	Harold H. Shlevin
	Title:	 	Chief Executive OfficerExhibit 10.1

 

STOCK
REDEMPTION AGREEMENT

 

THIS
STOCK REDEMPTION AGREEMENT (this “Agreement”) is made effective as of January 1, 2019 (the “Effective
Date”) by and among Zoned Properties, Inc., a Nevada corporation (“Company”), and the shareholders
set forth on the signature page hereto (“Sellers”).

 

RECITALS

 

A. Sellers
collectively own an aggregate of 5,640,004 of shares of Company’s common stock, par value $0.001 per share, as set forth
on Exhibit A attached hereto (the “Sellers Shares”).

 

B. During
May 2018, Company entered into lease agreements and confidential advisory services agreements with related-party entities affiliated
with the Sellers, including: (a) that certain lease agreement dated May 1, 2018, by and between a company affiliate, Chino Valley
Properties, LLC (“Chino Valley”), as landlord, and Broken Arrow Herbal Center, Inc. (“Broken Arrow”),
as tenant (“Chino Valley Lease”); (b) that certain lease agreement dated May 1, 2018, by and between a company
affiliate, Zoned Arizona Properties, LLC (“Zoned Arizona”), as landlord, and CJK, Inc. (“CJK”),
as tenant (“CJK Lease,” collectively with Chino Valley Lease the “Leases”); (c) that certain
confidential advisory services agreement, dated May 1, 2018, by and between Chino Valley and Broken Arrow (“Broken Arrow
CASA”); and that certain confidential advisory services agreement, dated May 1, 2018, by and between Zoned Arizona and
CJK (“CJK CASA,” collectively with Chino Advisory agreement the “Advisory Agreements”).

 

C. Pursuant
to the Advisory Agreements, each of Broken Arrow and CJK agreed to pay, respectively, the Company ten percent (10%), respectively,
of Broken Arrow’s and CJK’s gross revenue (“Gross Revenue Fee”).

 

D. Broken
Arrow and CJK each desire to amend the Advisory Agreements to reduce the Gross Revenue Fee to 0% in exchange for Company redeeming
the 5,640,004 Sellers Shares.

 

E. To
determine whether redeeming the Sellers Shares was in the best interests of Company and its shareholders, in October 2018, Company’s
Board of Directors approved the formation of an independent special committee of the board of directors (“Special Committee”),
engaged of its independent directors.

 

F. After
review and analysis of various considerations, the Special Committee approved entering into the amendment to the Advisory Agreements
in exchange for, among other items, redemption of all 5,640,004 of Sellers Shares.

 

G. Company
intends to redeem all Sellers Shares, and Sellers intend to sell Sellers Shares upon the terms and conditions set forth in this
Agreement.

 

    	 	1	 

     

    

 

H. Sellers
and Company desire to memorialize in this Agreement their mutual agreement regarding the redemption of the Shares.

 

NOW,
THEREFORE, in consideration of the mutual covenants and the promises contained herein, and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, do hereby agree
as follows:

 

AGREEMENT

 

1. Stock
Redemption. Subject to the terms and conditions of this Agreement, Sellers hereby agree to convey, transfer, and assign to
Company and Company hereby agrees to redeem from Sellers the Sellers Shares, free and clear of any and all Liens, for the Redemption
Consideration. Sellers hereby agree that this Agreement is and will be irrevocable and will survive and will not be affected by
the subsequent death, disability, incapacity, bankruptcy or insolvency of Sellers. Upon Sellers’ execution of this Agreement,
Sellers will deliver to Company for cancellation the original stock certificate(s) representing the Sellers Shares, duly endorsed
for transfer to Company.

 

As
used herein, “Lien” means any mortgage, lien (statutory or otherwise), security interest, charge, adverse right,
interest or claim, pledge, license, option, conditional sales contract, assessment, levy, easement, covenant, condition, reservation,
hypothecation, restriction, title defect, exception, limitation, charge, possibility of reversion, right of refusal, voting trust
or agreement, proxy, marital or community property interest, or encumbrance of any nature whatsoever.

 

(a) Redemption
Consideration. Upon receipt by Company of all original stock certificates representing and evidencing the Sellers Shares,
duly endorsed for transfer or accompanied by stock transfer powers or other appropriate transfer instruments duly executed in
blank or in favor of Company (or affidavits of lost or misplaced certificates evidencing the same) and otherwise in a form acceptable
for transfer on the books and records of Company (the “Original Certificates”), the Parties shall enter into
the following agreements (collectively, the “Redemption Consideration”):

 

(i) Amend
the Advisory Agreements by entering into that certain First Amendment to the Broken Arrow CASA, whereby Company shall reduce the
Gross Revenue Fee from 10% of gross revenue to 0% of gross revenue. Company shall also enter into that certain First Amendment
to the CJK CASA whereby Company shall reduce the Gross Revenue Fee from 10% of gross revenue to 0% of gross revenue.

 

(ii) Amend
that certain Convertible Debenture dated January 9, 2017, by and between Company and Alan Abrams, by extending the Maturity Date
from January 9, 2022 until January 9, 2030.

 

(iii) Amend
the Chino Valley Lease by entering into that certain First Amendment to the Chino Valley Lease whereby Company shall increase
its base rent from $35,000 per month to $40,000 per month plus any applicable fees and taxes to be adjusted with base rent.

 

    	 	2	 

     

    

 

(b) Title.
Title to Sellers Shares shall pass to Company upon execution of this Agreement and the payment of the Purchase Price for Sellers
Shares as provided in this Section 1.

 

(c) Representations
and Warranties of Sellers. Sellers hereby represent and warrant as follows to Company, knowing that Company is relying on
the statements contained herein as a basis for entering into this Agreement with Sellers on the terms hereof:

 

(i) Sellers
are the record and beneficial owners of the Sellers Shares and hold the Sellers Shares free and clear of any lien, encumbrance,
pledge, charge, or claim whatsoever (except for such liens, encumbrances, pledges, charges, or claims held by Company) with all
requisite right and power to sell, assign, transfer, and deliver the Sellers Shares to Company. Upon execution of this Agreement,
Company will have good, valid, marketable title to the Sellers Shares, free and clear of any lien, claim, charge, encumbrance,
limitation, agreement, and restriction whatsoever.

 

(ii) There
are no actions, suits, proceedings, or claims pending or threatened with respect to or in any manner affecting the ownership of
the Sellers Shares by Sellers, or that are reasonably likely to prohibit or restrain the ability of Sellers to enter into this
Agreement or consummate the transactions contemplated hereby.

 

(iii) Each
Seller has the full legal right, power, and all authority required to enter into and perform such Seller’s obligations under
this Agreement and otherwise carry out his or its obligations hereunder. No approval or consent of any governmental or regulatory
authority or other third party is necessary in connection herewith. The execution and delivery of this Agreement by Sellers has
been duly authorized by all requisite action by each Seller. This Agreement constitutes and, upon execution and delivery, will
constitute a valid and binding agreement and obligation of Sellers, enforceable against them in accordance with its terms.

 

(iv) The
execution and delivery of this Agreement and the consummation of the transactions contemplated hereby will not conflict with,
violate, or result in the breach by Sellers of, or constitute a default under (or an event that with notice or lapse of time or
both would become a default), or give to others any rights of termination, amendment, acceleration (or cause any acceleration
of any obligation with respect to any specific provision), or cancellation (with or without notice, lapse of time or both) of,
any credit facility, material loan, mortgage, lien, agreement, contract, instrument, order, judgment, award, decree, or any other
restriction of any kind or character to which any material assets or properties of Sellers is subject or by which Sellers are
bound. Nothing related to this Agreement results in a violation of any law, rule, regulation, order, judgment, injunction, decree
or other restriction of any court or governmental authority to which Sellers are subject (including federal and state securities
laws and regulations).

 

(v) Sellers
have such knowledge and experience in financial and business matter that Sellers are capable of evaluating the merits and risks
of redeeming Sellers Shares and of making an informed investment decision with respect thereto.

 

    	 	3	 

     

    

 

(vi) Sellers
acknowledge and agree that, except as set forth in this Agreement, Sellers have neither received nor are entitled to rely upon
any representations or warranties from Company or any shareholder, director, officer, employee, counsel, representative, or agent
thereof. Subject to the preceding sentence: (i) Company has made available all additional information that Sellers have requested
in connection with the transactions contemplated by this Agreement; (ii) Sellers have been provided the opportunity to ask questions
of and receive answers from Company concerning the terms and conditions of the redemption of Sellers Shares and this Agreement;
(iii) Sellers have been provided the opportunity to obtain any additional information (to the extent Company had such information
or could acquire it without unreasonable effort or expense) necessary to verify the accuracy of information otherwise furnished
by Company or its officers. Sellers have investigated the sale of Sellers Shares to the extent Sellers deemed necessary or desirable
and Company has provided Sellers with any assistance Sellers have requested in connection therewith.

 

(vii) Sellers
understand that no governmental agency has made any finding or determination as to the fairness of the sale by Sellers of the
Sellers Shares, or this Agreement.

 

(viii) Sellers
have been advised and given the opportunity to seek advice from Sellers’ own respective independent legal counsel and other
independent professional advisors with respect to this Agreement. Sellers have obtained, to the extent Sellers deemed necessary,
Sellers own professional legal, accounting, investment, and tax advice with respect to the risks inherent in retaining or selling
the Sellers Shares and the terms and conditions of this Agreement. Sellers further represent and warrant that Sellers have relied
solely upon Sellers’ own respective independent legal counsel and professional advisors and/or Sellers’ own respective
independent investigation, review, and analysis of the valuation of the Sellers Shares and the terms and conditions of this Agreement
and the transactions contemplated hereby. Sellers are not relying on Company or any of its directors, stockholders, officers,
employees, counsel, representatives, or agents for legal, accounting, investment, or tax advice.

 

(ix) Sellers
acknowledge and agree that Sellers are receiving fair and adequate consideration for the Sellers’ Shares.

 

Sellers
agree that Sellers shall immediately notify Company in writing if any of the above representations and warranties becomes untrue
prior to the Closing Date.

 

(d) Representations
and Warranties of Company. Company hereby represents and warrants as follows to Sellers, knowing that Sellers are relying
on the statements contained herein as a basis for entering into this Agreement with Company on the terms hereof:

 

(i) Company
is a duly organized and validly existing corporation and is in good standing under the laws of the State of Nevada.

 

(ii) There
are no actions, suits, proceedings, or claims pending or threatened that relate directly or indirectly to the redemption of the
Shares.

 

(iii) Company
has the right to enter into and perform its obligations under this Agreement, and no approvals or consent of any governmental
or regulatory authority or other third parties is necessary in connection herewith. The execution and delivery by Company of this
Agreement has been duly authorized by all requisite Company action. This Agreement constitutes and, upon execution and delivery,
will constitute a valid and binding agreement and obligation of Company, enforceable against it in accordance with its terms.

 

    	 	4	 

     

    

 

(iv) The
execution and delivery of this Agreement and the consummation of the transactions contemplated hereby will not violate or result
in the breach by Company of, or constitute a default under, or conflict with, or cause any acceleration of any obligation with
respect to any provision or restriction of any material loan, mortgage, lien, agreement, contract, instrument, order, judgment,
award, decree, or any other restriction of any kind or character to which any material assets or properties of Company is subject
or by which Company is bound.

 

2. Delivery
of Instruments of Transfer. Upon the execution of this Agreement, Sellers shall deliver to Company all Original Certificates.
Upon receipt of the Original Certificates and such stock power, Company shall amend its records simultaneously herewith to reflect
the changes in the Sellers Shares purchased pursuant to the transactions described herein.

 

3. Severability.
If any provision of this Agreement, as applied to any party or any circumstances, is adjudged by a court of competent jurisdiction
to be invalid or unenforceable, the same will in no way affect any other provision of this Agreement or the validity or enforceability
of this Agreement.

 

4. Confidentiality.
Sellers agree to keep the terms of this Agreement (“Agreement-Related Information”) in the strictest confidence
and not reveal, unless legally compelled to do so, any Agreement-Related Information to any persons except its legal counsel and
its financial advisors, and to them only provided that they first agree, for the benefit of Company, to keep Agreement-Related
Information confidential. Nothing in this Section shall be construed to prevent Sellers from disclosing Agreement-Related
Information to the extent required by a lawfully issued subpoena or duly issued court order; provided that you provide
Company with advance written notice and a reasonable opportunity to contest such subpoena or court order. Notwithstanding the
foregoing, Company shall file this Agreement publicly with applicable regulatory authorities if required by applicable securities
laws.

 

5. Costs
and Expenses of Enforcement. In the event of the failure of a party to comply with any provision of this Agreement, such party
shall pay any and all costs and expenses, including reasonable attorneys’ fees arising out of or resulting from such default
(including any fees arising in connection with an appeal), or in pursuing any remedy hereunder or by the laws of the state of
Arizona, whether such remedy is pursued by filing suit or otherwise.

 

6. Interpretation
and Construction. This Agreement constitutes the entire agreement and understanding among the parties pertaining to the subject
matter contained herein and supersedes all prior and contemporaneous agreements, representations, and understandings of the parties.
No covenant, representation, or condition not expressed in this Agreement shall affect or be deemed to interpret, change, or restrict
the express provisions hereof. No supplement, modification, or amendment of this Agreement shall be binding unless executed in
writing by all the parties. The headings in this Agreement are for the convenience of reference only and shall not affect the
interpretation of this Agreement.

 

    	 	5	 

     

    

 

7. Benefit.
This Agreement shall be binding upon and inure to the benefit of the parties hereto and their permitted successors and assigns.

 

8. Governing
Law; Consent to Jurisdiction. This Agreement and any controversy arising out of or relating to this Agreement shall be governed
by and construed in accordance with the laws of the State of Arizona, without regard to conflict of law principles. Each party
hereto irrevocably submits to the exclusive jurisdiction of the federal and state courts located in the State of Arizona for the
purposes of any action or proceeding arising out of or relating to this Agreement. Each party hereto hereby consents to jurisdiction
and agrees that venue shall lie in the state or federal courts within Maricopa County, Arizona with respect to any claim or cause
of action arising under or relating to this Agreement. Each party hereto hereby waives any objection based on forum non conveniens
and waives any objection to venue in any action instituted hereunder. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY
WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND THEREFORE, EACH PARTY HEREBY IRREVOCABLY
AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY
ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

 

    	 	6	 

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement effective as of the date first set forth above.

 

	 	COMPANY:
	 	 	 
	 	ZONED
    PROPERTIES, INC.
	 	 	 
	 	By:	/s/
    Bryan McLaren
	 	 	Bryan
    McLaren, Chief Executive Officer

 

	 	SELLERS:
	 	 	 
	 	CLAYTON
    ABRAMS REVOCABLE TRUST
	 	 	 
	 	Sign
    Name:	/s/
    Alan B. Abrams
	 	Print
    Name:	Alan
    B. Abrams
	 	Title:	Trustee

 

	 	KYLE
    ABRAMS REVOCABLE TRUST
	 	 
	 	Sign
    Name:	/s/
    Alan B. Abrams
	 	Print
    Name:	Alan
    B. Abrams
	 	Title:	Trustee
	 	 	 
	 	/s/
    Christopher Carra
	 	Christopher
    Carra
	 	 	 
	 	/s/ Alan B. Abrams
	 	Alan B. Abrams

     

     

    

 

EXHIBIT
A

 

Sellers
Shares

 

	Name	 	Number of Shares	 
	Christopher Carra	 	 	2,028,335	 
	 	 	 	 	 
	Alan B. Abrams	 	 	3,511,669	 
	 	 	 	 	 
	Clayton Abrams Revocable Trust	 	 	50,000	 
	Alan B. Abrams, TTEE	 	 	 	 
	U/A DTD December 6, 2012	 	 	 	 
	 	 	 	 	 
	Kyle Abrams Revocable Trust	 	 	50,000	 
	Alan B. Abrams, TTEE	 	 	 	 
	U/A DTD December 6, 2012

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]